Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al
Case Number:
2:14-cv-02571
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Brownstein Hyatt
- Glancy Prongay
- Greenberg Traurig
- Green & Noblin PC
- Lowenstein Sandler
- Mayer Brown
- Morgan Lewis
- Morrison Foerster
- Pomerantz LLP
- Robbins Geller
- Tostrud Law Group
- Wilson Sonsini
Companies
Sectors & Industries:
-
January 25, 2019
Ernst & Young Settles Last Marrone Bio Claim For $775K
Investors in Marrone Bio Innovations Inc. told a California federal judge on Thursday that they have settled the last remaining claim in their suit over the pesticide maker's alleged financial misrepresentations, saying they've reached a $775,000 deal with Marrone auditor Ernst & Young LLP.
-
May 05, 2017
Ernst & Young, Marrone Bio Investors In Settlement Talks
Ernst & Young LLP and Marrone Bio Innovations Inc. investors have urged a California federal judge to pause discovery in a suit over the auditor's alleged role in the bio-based pesticide maker's financial misrepresentations, saying they are meeting to explore a potential resolution.
-
March 21, 2017
Ernst & Young Must Face Marrone Bio Investor Claims: Judge
A California federal judge has shut down a bid by Ernst & Young LLP to toss class claims by Marrone Bio Innovations Inc. investors over the auditor's alleged role in the bio-based pesticide maker's financial misrepresentations, saying investors showed that Ernst & Young certified Marrone's financial statements.
-
August 02, 2016
Marrone Bio Investors Say Ernst & Young Must Face Claims
A class of Marrone Bio Innovations Inc. shareholders on Monday urged a California federal court not to dismiss claims against Ernst & Young LLP over its alleged role in the bio-based pesticide maker's financial misrepresentations, arguing the firm is liable for the false financial statements at issue.
-
May 26, 2016
Marrone Bio Reaches $12M Deal In Securities Class Action
Marrone Bio Innovations Inc. agreed to pay $12 million to settle a shareholder class action alleging that the bio-based pesticide maker lied to investors about its financial condition, according to a proposal Wednesday that said the sum would come from insurance so the company wouldn’t go broke.